Tuesday, October 07, 2025

Pancreatic Cancer clues could be hiding in plain sight — in your mouth. Read what study says

A recent study established a link between poor oral health and pancreatic cancer risk by identifying 27 species of bacteria and fungi that may contribute to the disease. Conducted by NYU researchers, the study analysed saliva samples from 122,000 adults.

A recent study published in JAMA Oncology made a disturbing revelation about how certain bacteria and fungi in mouth can significantly increase risk of pancreatic cancer by three-fold. According to the new research, conducted by NYU Langone Health and Perlmutter Cancer Center, a total of 27 types of bacterial and fungal species were identified in the mouth’s microbiome that may contribute to the one of the deadliest cancers.

"Altogether, we summarized the effects of these 27 microbial species by creating a risk score that combines each species’ effect size and abundance," co-senior study author and professor of population health at NYU Grossman School of Medicine, Jiyoung Ahn, informed Fox News Digital. He added, "Using this approach, we found that individuals with higher scores had a 3.5-fold increased risk of developing pancreatic cancer."

How is poor oral health linked to pancreatic cancer?

Around 122,000 healthy adults were surveyed whose saliva samples were collected and analysed. These individuals were followed for nine years. Oral microbiota found in 445 patients, who developed pancreatic cancer, were compared with that of 445 randomly selected cancer-free participants.

The investigators considered factors such as medical history, smoking habits, race and age during the study. The findings revealed 24 species of bacteria and fungi that were associated with an increased or lowered risk of pancreatic cancer. Meanwhile, it was observed that three more bacteria were linked to both gum disease and pancreatic cancer.

According to Jiyoung Ahn, who is also an associate director for population science at NYU Perlmutter Cancer Center, Oral microbiome profiling could serve as a non-invasive biomarker to identify individuals at elevated risk. These vulnerable individuals can be treated through early detection methods for pancreatic cancer.

This study established the connection between poor oral health and pancreatic cancer with respect to specific species of bacteria that are potential culprits. Hence, good oral health is not only important to wade off caries and bad breath but also significantly impacts overall systemic health, making regular brushing, flossing and dental care a must.

Shedding light on the findings, spokesperson for the American Dental Association, Kumar, who was not involved in the study, said, "We cannot separate the oral cavity or oral diseases from diseases that happen elsewhere in the body," Fox News Digital reported.

I know a man who had very poor oral health, when he went to doctor with pain in head, he was diagnosed with brain cancer and died within a few days. Please be careful with all oral issues, get it checked whenever there's a doubt. Prevention is better than cure. Good luck to all. Whenever you've dental appointments, ask your dentist to take a good look of your entire mouth, any red/ white spots, any cuts, any difference in colour in your gums and so on.

Good luck to all for good health and happiness. 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

 

 

Labels: , , ,

Saturday, December 21, 2024

Pancreatic Cancer Can Soon be Treated at Home!

A fresh glimmer of hope has emerged for pancreatic cancer patients. A first-of-its-kind telehealth-based cancer clinical trial offers patients targeted therapy from the comfort of their homes. Dubbed "smart drugs," these precision therapies singularly pinpoint the genetic anomalies responsible for driving the proliferation of cancer cells.
 
 The primary objective of this trial was to investigate fibroblast growth factor receptors (FGFR), identified in around one percent of patients with pancreatic cancer. Through the implementation of telehealth techniques in this study, patients throughout the United States can gain access to oral targeted drug therapies conveniently, eliminating the need for extensive travel.
Pancreatic Cancer
 
Dr. Sameek Roychowdhury, a medical oncologist at The Ohio State University Cancer Center, stresses that bringing clinical trial treatments to patients and collaborating with local oncologists nationwide significantly enhances patient access to these therapies. This approach also improves the potential for impactful discoveries through the enrollment of larger groups of patients, according to a press statement.

Pancreatic cancer, though rare, is a highly aggressive disease that impacts approximately 64,000 people every year. Detection often takes place during the advanced stages, which complicates the treatment process. Surgical procedures show promise in the early stages, yet early identification remains a challenge, which limits the availability of recommended treatment selections. This study aims to enhance the availability of clinical trials for targeted drug therapies, thus addressing a pivotal void in pancreatic cancer treatment. 
 
In cancer patients, numerous gene mutations could be present, but identifying the ones influencing cancer behavior and utilizing innovative treatments to address these mutations forms the foundation of 'smart drug’ – or precision cancer medicine – research, says Roychowdhury. Clinical trials for precision oncology are hindered by the rarity of certain gene mutations, which deters pharmaceutical companies from undertaking such trials due to a lack of interest and feasibility.

This trial draws inspiration from FGFR research supported by Gateway for Cancer Research, a nonprofit organization dedicated to funding early-phase clinical trials for various types of cancer. Gateway is a proponent of decentralized oncology research and seeks to raise awareness about telemedicine-based trials, ensuring that patients comprehend their options no matter how close they are to a research site.

With ten years of expertise in FGFR intelligent medications, Dr. Roychowdhury spearheads this groundbreaking therapy. Along with the clinical trial, his team has established a patient registry to advance research into rare forms of pancreatic cancer.


This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
https://cancersupportindia.blogspot.com  for infor on cancer and health related topics
https://GSiyers home remedies.blogspot.com   is the latest addition to my blogs. I'm going to add posts there, do give me your valuable feed back on my blogs. Thanks a lot, take care, be healthy and be happy.

Labels: , , ,

Thursday, September 19, 2024

The Sneakiest Cancers And How To Spot Them Before It Is Too Late

Cancer is an extremely complex and dangerous group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.

According to the World Health Organisation, cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or 1 in 6 deaths. Lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women.

Even though there have been significant advancements in medical research and technology that have helped improve the easy and timely detection of various cancers, some types exhibit a sneaky nature, making them challenging to diagnose and treat.

 Why Is Bowel Cancer Mistaken For IBS? Doctor Shares Symptoms That Can Be Confusing   

 According to experts, most people who lose their lives because of cancer are diagnosed at a very later stage, when treatments do not work. There are more than 100 types of cancer, and some are more common than others.

Pancreatic cancer

Often called the "silent killer" due to the absence of any noticeable signs until the disease has advanced, pancreatic cancer is among the deadliest. A few signs include:

 

Stomach pain

  • Unintentional weight loss
  • Digestive issues
However, these are common with many other ailments and initially cannot be attributed to just cancer. And so, pancreatic cancer is frequently diagnosed at an advanced stage, reducing treatment options and overall survival rates. 1

Skin cancer

Skin cancer is the most common form of the disease, which affects more than a million people yearly across the world. A few signs include:
  • Sores that take a long time to heal
  • Raised, scaly red patches
  • Small and smooth lumps on the skin
  • Pale skin that resembles scars
  • Sores or growths that bleed
  • Pink growths with raised edges

Lung cancer

Lung cancer is the second most common cancer worldwide with over 2 million reported cases every year.

According to doctors, it can be extremely subtle in its initial stages. Early symptoms like cough and chest discomfort can be attributed to other respiratory problems. Also, this cancer mostly lacks obvious symptoms until it reaches an advanced stage. 2

Kidney cancer

Most people do not report early stages of kidney cancer because it does not involve any pain or recognizable signs. 

According to doctors, this cancer progresses quietly but aggressively, and as the tumour grows, you may experience signs like:

  • Blood in the urine
  • Severe back pain
  • Unintentional weight loss

Brain cancer

Brain cancer, also known as bitemporal hemianopsia, is a deadly ailment that arises due to tumours or gliomas which form a thin layer of tissue that covers the spinal cord and brain. 

 

Even though it may exhibit subtle signs like headaches or fatigue, later as the tumour grows, you may suffer from seizures or fits - particularly in those patients who do not have a medical history. According to experts, nearly one-third of patients diagnosed with brain tumour report a seizure before being diagnosed with a tumour.

A brain tumour also affects the brain’s processing speed leading to cognitive decline which is very slow.

What can be done to identify cancer signs?

According to the Indian Cancer Society, paying attention to even small details and mild symptoms are extremely important. 

Doctors say if those, including high-risk groups, are aware of the possible signs and symptoms of cancer, and empowered to contact their doctors as soon as they notice any of these signs or symptoms, it can facilitate the early diagnosis of cancer.

Every abnormality in the body should be dealt with carefully.

 

 

Labels: , , , ,

Tuesday, May 14, 2024

Pancreatic Cancer Can Soon be Treated at Home!

A fresh glimmer of hope has emerged for pancreatic cancer patients. A first-of-its-kind telehealth-based cancer clinical trial offers patients targeted therapy from the comfort of their homes. Dubbed "smart drugs," these precision therapies singularly pinpoint the genetic anomalies responsible for driving the proliferation of cancer cells.
 
The primary objective of this trial was to investigate fibroblast growth factor receptors (FGFR), identified in around one percent of patients with pancreatic cancer. Through the implementation of telehealth techniques in this study, patients throughout the United States can gain access to oral targeted drug therapies conveniently, eliminating the need for extensive travel.

Dr. Sameek Roychowdhury, a medical oncologist at The Ohio State University Cancer Center, stresses that bringing clinical trial treatments to patients and collaborating with local oncologists nationwide significantly enhances patient access to these therapies. This approach also improves the potential for impactful discoveries through the enrollment of larger groups of patients, according to a press statement.

Pancreatic cancer, though rare, is a highly aggressive disease that impacts approximately 64,000 people every year. Detection often takes place during the advanced stages, which complicates the treatment process. Surgical procedures show promise in the early stages, yet early identification remains a challenge, which limits the availability of recommended treatment selections. This study aims to enhance the availability of clinical trials for targeted drug therapies, thus addressing a pivotal void in pancreatic cancer treatment.

In cancer patients, numerous gene mutations could be present, but identifying the ones influencing cancer behavior and utilizing innovative treatments to address these mutations forms the foundation of 'smart drug’ – or precision cancer medicine – research, says Roychowdhury. Clinical trials for precision oncology are hindered by the rarity of certain gene mutations, which deters pharmaceutical companies from undertaking such trials due to a lack of interest and feasibility.

This trial draws inspiration from FGFR research supported by Gateway for Cancer Research, a nonprofit organization dedicated to funding early-phase clinical trials for various types of cancer. Gateway is a proponent of decentralized oncology research and seeks to raise awareness about telemedicine-based trials, ensuring that patients comprehend their options no matter how close they are to a research site.
 
With ten years of expertise in FGFR intelligent medications, Dr. Roychowdhury spearheads this groundbreaking therapy. Along with the clinical trial, his team has established a patient registry to advance research into rare forms of pancreatic cancer.


This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
https://cancersupportindia.blogspot.com  for infor on cancer and health related topics
https://GSiyers home remedies.blogspot.com   is the latest addition to my blogs. I'm going to add posts there, do give me your valuable feed back on my blogs. Thanks a lot, take care, be healthy and be happy.

Labels: , , ,

Tuesday, April 02, 2024

Pancreatic Cancer Can Soon be Treated at Home!

A fresh glimmer of hope has emerged for pancreatic cancer patients. A first-of-its-kind telehealth-based cancer clinical trial offers patients targeted therapy from the comfort of their homes. Dubbed "smart drugs," these precision therapies singularly pinpoint the genetic anomalies responsible for driving the proliferation of cancer cells.

The primary objective of this trial was to investigate fibroblast growth factor receptors (FGFR), identified in around one percent of patients with pancreatic cancer. Through the implementation of telehealth techniques in this study, patients throughout the United States can gain access to oral targeted drug therapies conveniently, eliminating the need for extensive travel.

Dr. Sameek Roychowdhury, a medical oncologist at The Ohio State University Cancer Center, stresses that bringing clinical trial treatments to patients and collaborating with local oncologists nationwide significantly enhances patient access to these therapies. This approach also improves the potential for impactful discoveries through the enrollment of larger groups of patients, according to a press statement.

Pancreatic cancer, though rare, is a highly aggressive disease that impacts approximately 64,000 people every year. Detection often takes place during the advanced stages, which complicates the treatment process. Surgical procedures show promise in the early stages, yet early identification remains a challenge, which limits the availability of recommended treatment selections. This study aims to enhance the availability of clinical trials for targeted drug therapies, thus addressing a pivotal void in pancreatic cancer treatment.

In cancer patients, numerous gene mutations could be present, but identifying the ones influencing cancer behavior and utilizing innovative treatments to address these mutations forms the foundation of 'smart drug’ – or precision cancer medicine – research, says Roychowdhury. Clinical trials for precision oncology are hindered by the rarity of certain gene mutations, which deters pharmaceutical companies from undertaking such trials due to a lack of interest and feasibility.

This trial draws inspiration from FGFR research supported by Gateway for Cancer Research, a nonprofit organization dedicated to funding early-phase clinical trials for various types of cancer. Gateway is a proponent of decentralized oncology research and seeks to raise awareness about telemedicine-based trials, ensuring that patients comprehend their options no matter how close they are to a research site.
 
With ten years of expertise in FGFR intelligent medications, Dr. Roychowdhury spearheads this groundbreaking therapy. Along with the clinical trial, his team has established a patient registry to advance research into rare forms of pancreatic cancer.

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
https://cancersupportindia.blogspot.com  for infor on cancer and health related topics
https://GSiyers home remedies.blogspot.com   is the latest addition to my blogs. I'm going to add posts there, do give me your valuable feed back on my blogs. Thanks a lot, take care, be healthy and be happy.

Labels: , , , ,

Saturday, August 12, 2023

Pancreatic Cancer Can Soon Be Treated at Home!

 A fresh glimmer of hope has emerged for pancreatic cancer patients. A first-of-its-kind telehealth-based cancer clinical trial offers patients targeted therapy from the comfort of their homes. Dubbed "smart drugs," these precision therapies singularly pinpoint the genetic anomalies responsible for driving the proliferation of cancer cells. 

 Pancreatic Cancer

  The primary objective of this trial was to investigate fibroblast growth factor receptors (FGFR), identified in around one percent of patients with pancreatic cancer. Through the implementation of telehealth techniques in this study, patients throughout the United States can gain access to oral targeted drug therapies conveniently, eliminating the need for extensive travel.

Dr. Sameek Roychowdhury, a medical oncologist at The Ohio State University Cancer Center, stresses that bringing clinical trial treatments to patients and collaborating with local oncologists nationwide significantly enhances patient access to these therapies. This approach also improves the potential for impactful discoveries through the enrollment of larger groups of patients, according to a press statement.

Pancreatic cancer, though rare, is a highly aggressive disease that impacts approximately 64,000 people every year. Detection often takes place during the advanced stages, which complicates the treatment process. Surgical procedures show promise in the early stages, yet early identification remains a challenge, which limits the availability of recommended treatment selections. This study aims to enhance the availability of clinical trials for targeted drug therapies, thus addressing a pivotal void in pancreatic cancer treatment.

In cancer patients, numerous gene mutations could be present, but identifying the ones influencing cancer behavior and utilizing innovative treatments to address these mutations forms the foundation of 'smart drug’ – or precision cancer medicine – research, says Roychowdhury. Clinical trials for precision oncology are hindered by the rarity of certain gene mutations, which deters pharmaceutical companies from undertaking such trials due to a lack of interest and feasibility.

This trial draws inspiration from FGFR research supported by Gateway for Cancer Research, a nonprofit organization dedicated to funding early-phase clinical trials for various types of cancer. Gateway is a proponent of decentralized oncology research and seeks to raise awareness about telemedicine-based trials, ensuring that patients comprehend their options no matter how close they are to a research site.

With ten years of expertise in FGFR intelligent medications, Dr. Roychowdhury spearheads this groundbreaking therapy. Along with the clinical trial, his team has established a patient registry to advance research into rare forms of pancreatic cancer. 
 
Patient enrollment for the trial is set to begin in the second half of 2023. To find out more about taking part in the research or becoming a member of the registry, reach out to Sameek.Roychowdhury@osumc.edu.

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
https://cancersupportindia.blogspot.com  for infor on cancer and health related topics
https://GSiyers home remedies.blogspot.com   is the latest addition to my blogs. I'm going to add posts there, do give me your valuable feed back on my blogs. Thanks a lot, take care, be healthy and be happy.

Labels: , ,

Wednesday, March 23, 2022

Ketogenic diet plus triple drug can prevent pancreatic cancer?

The latest study suggests that when paired with a triple-drug therapy, a ketogenic diet that is low in carbohydrates and protein and high in fat may help to destroy pancreatic cancer cells.

The study's findings were published in the journal 'Med.' The ketogenic diet decreased glucose (sugar) levels in tumours in laboratory trials, implying that the diet helped starve cancer. Additionally, this diet increased the amount of ketone bodies produced by the liver, putting additional strain on cancer cells. According to the study, by disrupting cancer cells, the ketogenic diet generated a microenvironment in which Tgen's triple-drug therapy (a mix of gemcitabine, nab-paclitaxel, and cisplatin) was more effective at eradicating the tumour.

"By reducing glucose availability, the ketogenic diet may enhance the efficiency of chemotherapy," TGen Distinguished Professor Professor Daniel D. Von Hoff, M.D., is widely regarded as one of the best authorities on pancreatic cancer in the United States. Dr Von Hoff is one of the study's authors and the therapy's creator.

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

 

 

 

Labels: , , , , , ,